Filana Therapeutics, Inc. Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount
Filana Therapeutics, Inc. (FLNA) had Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount of $19.90 million as of 2026-03-31, per its 10-Q filed 2026-05-07.
Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure
us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions · last filed 2026-05-07
- 2026-03-31: Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount $19.90M.
- 2025-09-30: Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount $28.90M.
- 2025-06-30: Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount $30.60M.
- 2025-03-31: Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount $31.80M.
| Period end | Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount |
|---|---|
| 2026-03-31 | $19.90M 10-Q · filed 2026-05-07 |
| 2025-09-30 | $28.90M 10-Q · filed 2025-11-12 |
| 2025-06-30 | $30.60M 10-Q · filed 2025-08-14 |
| 2025-03-31 | $31.80M 10-Q · filed 2025-05-08 |
| 2024-09-30 | $45.20M 10-Q · filed 2024-11-07 |
| 2024-06-30 | $22.60M 10-Q · filed 2024-08-08 |
| 2024-03-31 | $21.30M 10-Q · filed 2024-05-10 |
| 2023-09-30 | $8.00M 10-Q · filed 2023-11-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 |